Aggression and innovation rather than palliation

Radiotherapy and Oncology

Volumn 89, Issue 1, 2008, Pages 123-

  Chufal, K S ^a   Nangia, S ^a  

^a Batra Hospital India   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRESSION; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; HEAD AND NECK CANCER; LETTER; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DOSE FRACTIONATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PALLIATIVE CARE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY DOSAGE; TREATMENT OUTCOME;

EID: 53049102150     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.08.004     Document Type: Letter

References (7)

1. Agarwal J.P., Nemade B., Murthy V., et al. Hypofractionated, palliative radiotherapy for advanced head and neck cancer. Radiother Oncol 89 (2008) 51-56
2. Mohanti B.K., Umapathy H., Bahadur S., et al. Short course palliative radiotherapy of 20 Gy in 5 fractions for advanced and incurable head and neck cancer: AIIMS study. Radiother Oncol 71 (2004) 275-280
3. Calais G., Alfonsi M., Bardet E., et al. Randomized trial of radiotherapy versus concomitant chemotherapy and radiation therapy for advanced stage oropharynx carcinoma. J Natl Cancer Inst 91 (1999) 2081-2086
4. Garden A.S., Harris J., Trotti A., et al. Long term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinoma: a phase II trial of the radiation therapy oncology group (RTOG 99-14). Int J Radiat Oncol Biol Phys 71 (2008) 1351-1355
5. Chufal K.S., Nangia S., Tyagi A., et al. Ghosh. 2439: intensity modulated radiotherapy using compensators for head and neck cancer patients: impact of dosimetric parameters on clinical outcome. Int J Radiat Oncol Biol Phys 66 (2006) S453-S454
6. Villar A., Martinez J.C., and de Serdio J.L. Chemoradiation for advanced head and neck cancer: potential for improving results to match those of current treatment modalities for early-stage tumors - long-term results of hyperfractionated chemoradiation with carbogen breathing and anemia correction with erythropoietin. Int J Radiat Oncol Biol Phys 70 (2008) 1382-1388
7. Rusthoven K.E., Raben D., and Chen C. Improved survival in patients with stage III-IV head and neck cancer treated with radiotherapy as primary local treatment modality. Int J Radiat Oncol Biol Phys 72 (2008) 343-350